Erlotinib vs Losartan

Erlotinib vs Losartan: Overview

This comparison examines the pharmacological differences between Erlotinib and Losartan.

Mechanism of Action

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Losartan: Angiotensin II receptor type 1 antagonist.

Pharmacokinetics

Half-life: Erlotinib — 36 hours; Losartan — 2 hours.

Chemical Properties

Molecular Formula: Erlotinib — C22H23N3O4; Losartan — C22H23ClN6O.

Molecular Weight: Erlotinib — 393.4380 g/mol; Losartan — 422.9200 g/mol.

Type: Erlotinib — Small molecule; Losartan — Small molecule.